Lin Hui, Cai Xiujun
The Department of General Surgery of Sir Run Run Shaw Hospital, Medical College, Zhejiang University, Hangzhou 310016, China.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2006 Jun;23(3):678-83.
Microencapsulation of cells or tissue fragments represents a potentially effective method to prevent graft rejection in allotransplantation and xenotransplantation without the need of immunosuppression, but the functional survival of all trial grafts is still limited. Usually, graft failure is mainly interpreted as the consequence of the progressive fibrotic overgrowth of capsules, the insufficient supply of oxygen and nutrition to the encapsulated graft, and the dysfunction of the encapsulated graft induced by small proinflammatory factors. These detrimental factors are interrelatd with the microcapsules, the implanted graft, and the transplantation site. This article reviews and summarizes the advance and the limitation of microencapsulated grafts transplantation in the above-mentioned aspects.
细胞或组织碎片的微囊化是一种潜在有效的方法,可在无需免疫抑制的情况下防止同种异体移植和异种移植中的移植物排斥,但所有试验性移植物的功能存活仍然有限。通常,移植物失败主要被解释为胶囊进行性纤维化过度生长、对包封移植物的氧气和营养供应不足以及小促炎因子诱导的包封移植物功能障碍的结果。这些有害因素与微囊、植入的移植物和移植部位相互关联。本文综述并总结了微囊化移植物移植在上述方面的进展和局限性。